Large-cell neuroendocrine carcinoma (LCNC) is a rare tumour characterized by aggressive biological behaviour and poor prognosis. Due to its rarity and the lack of randomized clinical trials, the best treatment is still under debate. Some recent reports indicate that adjuvant chemotherapy (CT) may have a beneficial effect on survival. Our goal was to evaluate this finding using a large series of patients with neuroendocrine tumours obtained from the European Society of Thoracic Surgeons database.

Adjuvant chemotherapy for large-cell neuroendocrine lung carcinoma: results from the European Society for Thoracic Surgeons Lung Neuroendocrine Tumours Retrospective Database / Filosso, Pier Luigi; Guerrera, Francesco; Evangelista, Andrea; Galassi, Claudia; Welter, Stefan; Rendina, Erino Angelo; Travis, William; Lim, Eric; Sarkaria, Inderpal; Thomas, Pascal Alexandre. - In: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. - ISSN 1873-734X. - 52:2(2017), pp. 339-345. [10.1093/ejcts/ezx101]

Adjuvant chemotherapy for large-cell neuroendocrine lung carcinoma: results from the European Society for Thoracic Surgeons Lung Neuroendocrine Tumours Retrospective Database

FILOSSO, Pier Luigi;
2017

Abstract

Large-cell neuroendocrine carcinoma (LCNC) is a rare tumour characterized by aggressive biological behaviour and poor prognosis. Due to its rarity and the lack of randomized clinical trials, the best treatment is still under debate. Some recent reports indicate that adjuvant chemotherapy (CT) may have a beneficial effect on survival. Our goal was to evaluate this finding using a large series of patients with neuroendocrine tumours obtained from the European Society of Thoracic Surgeons database.
2017
52
2
339
345
Adjuvant chemotherapy for large-cell neuroendocrine lung carcinoma: results from the European Society for Thoracic Surgeons Lung Neuroendocrine Tumours Retrospective Database / Filosso, Pier Luigi; Guerrera, Francesco; Evangelista, Andrea; Galassi, Claudia; Welter, Stefan; Rendina, Erino Angelo; Travis, William; Lim, Eric; Sarkaria, Inderpal; Thomas, Pascal Alexandre. - In: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. - ISSN 1873-734X. - 52:2(2017), pp. 339-345. [10.1093/ejcts/ezx101]
Filosso, Pier Luigi; Guerrera, Francesco; Evangelista, Andrea; Galassi, Claudia; Welter, Stefan; Rendina, Erino Angelo; Travis, William; Lim, Eric; Sarkaria, Inderpal; Thomas, Pascal Alexandre
File in questo prodotto:
File Dimensione Formato  
035_Adjuvant chemotherapy for LCNC_results from the ESTS Lung Neuroendocrine Tumours Retrospective Database..pdf

Accesso riservato

Dimensione 259.14 kB
Formato Adobe PDF
259.14 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1294930
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 45
  • ???jsp.display-item.citation.isi??? 37
social impact